A proposed mechanism for the upregulation of FASN transcription is through the activation of growth factor receptor (GFR) signaling pathways such as the epidermal growth factor receptor (EGFR), epidermal growth factor receptor 2 (HER2) and platelet-derived growth factor receptor (PDGFR) in tumor cells. Here, FASN is linked to neoplasm.